SCHEMBL20026475

SCHEMBL20026475

CC1(C)c2ccccc2-c2ccc(-c3ccc4c(c3)oc3ccccc34)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.41
HCRTR1 O43613 1/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
PGR P06401 1/20 0.39
MAOA P21397 2/20 0.38
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
ALOX5 P09917 1/20 0.37
PRKDC P78527 1/20 0.37
PDK2 Q15119 2/20 0.36
NPC1 O15118 4/20 0.35
RAB9A P51151 4/20 0.35
MAOB P27338 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12203283 0.96 PDK2 (0.38) AHRHCRTR1PDK2
SCHEMBL24130691 0.93 AHR (0.39) AHRHCRTR1MEN1KMT2AMAPT
SCHEMBL22058559 0.92 HCRTR1 (0.38) AHRHCRTR1MEN1KMT2AMAPT
SCHEMBL14211431 0.92 AHR (0.38) AHRHCRTR1MEN1KMT2AMAPT
SCHEMBL16017880 0.91 HSP90AA1 (0.43) AHRMEN1KMT2AMAPTKDM4E
SCHEMBL14733775 0.91 MEN1 (0.44) AHRHCRTR1MEN1KMT2AMAPT
SCHEMBL18086158 0.91 HSP90AA1 (0.43) AHRMEN1KMT2AMAPTKDM4E
SCHEMBL10110498 0.91 HCRTR1 (0.36) AHRHCRTR1MEN1KMT2AMAPT
SCHEMBL22059161 0.91 HCRTR1 (0.39) AHRHCRTR1MEN1KMT2AMAPT
SCHEMBL13521080 0.91 HCRTR1 (0.39) AHRHCRTR1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542258-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-01-03 US disclosed
US-20200262825-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2020-08-20 US disclosed
US-10689402-B2 Polycyclic aromatic compound and light emission layer-forming composition JNC CORPORATION (JP) 2020-06-23 US disclosed
US-20180094000-A1 POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMISSION LAYER-FORMING COMPOSITION KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180094000-A1 POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMISSION LAYER-FORMING COMPOSITION TYR, NOD2, AHR AHR 3/4885HCRTR1 117/4885MEN1 2692/4885
US-20200262825-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 AHR 51/4885HCRTR1 546/4885MEN1 316/4885
US-10689402-B2 Polycyclic aromatic compound and light emission layer-forming composition TYR, NOD2, AHR AHR 3/4885HCRTR1 117/4885MEN1 2692/4885
US-11542258-B2 Heterocyclic compound and organic light emitting device comprising the same CYP1A1, CRY1, CYP1B1 AHR 32/4885HCRTR1 399/4885MEN1 451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.